• Compact, fast time-of-flight mass spectrometers by TOFWERK optimized for small molecule applications;
• Innovative, on-line chemical ionization techniques for high sensitivity and in situ small molecule detection for stationary and mobile analysis;
• Sensitive, real-time TOF-MS solutions for semiconductor applications, ambient air analysis, cork analysis and diagnostics research from exhaled breath.
The partnership provides a basis for technology collaborations to advance instrument capabilities and for the development of novel analytical applications where high speed and ultra-sensitivity matter. TOFWERK expects to leverage Bruker’s commercial scale to accelerate penetration of selected market segments. This includes offering TOFWERK’s compact time-of-flight mass spectrometers (TOF-MS) for small molecule and volatiles analyses that require exceptional speed and sensitivity, as well as mobility and customization.
TOFWERK’s product portfolio includes specialized solutions based on TOF-MS analyzers and a variety of ionization methods, including real-time proton transfer reaction (PTR) chemical ionization, SIMS using fast ion beams in scanning electron microscopes (FIB-SEM), and inductively coupled plasma ionization (ICP). Novel point-of-need analytical solutions integrating Bruker’s recently acquired direct analysis in real time (DART) technology with TOF-MS are also on the development roadmap.
TOFWERK’s instruments are used in applications such as ambient air monitoring, breath analysis (for research use only), food and flavor analysis, and for airborne molecular contamination (AMC) monitoring in the semiconductor industry. Small footprints and robust engineering enable powerful TOF-MS analysis in demanding industrial environments and aboard mobile platforms, as well as in laboratory settings.
Mr. Jürgen Srega, President of the Bruker CALID group, said: “We are delighted to partner with TOFWERK to combine our innovations for novel analytical applications on fit-for-purpose scientific tools. Our recently acquired IonSense DART technology coupled to the TOFWERK Vocus CI-TOF-MS platform illustrates our technology synergies for the benefit of applied and industrial market customers in diverse application fields.”
Dr. Katrin Fuhrer, co-founder and CFO of TOFWERK, commented: "We are pleased to partner with Bruker as it allows us to leverage technical and operational synergies to better serve our customers through Bruker’s global commercial and service channels.”
Dr. Marc Gonin, co-founder and CEO of TOFWERK, added: “We are excited to work closely with Bruker to further accelerate the commercialization of compact, high-speed TOF-MS solutions for industrial and applied markets, based on ultra-high sensitivity and point-of-need analysis technologies developed at TOFWERK and Bruker.”
About TOFWERK AG
TOFWERK (tofwerk.com) is making the world a cleaner place through innovative solutions for chemical analysis. TOFWERK scientists and engineers design, manufacture, and optimize high performance mass spectrometers for new applications to support researchers and industrial customers around the world. TOFWERK instruments offer the speed and sensitivity of time-of-flight mass spectrometry with compact, robust construction to enable use in any environment and flexible design to accelerate new applications. TOFWERK’s product portfolio spans a diverse range of markets, including ambient air monitoring, breath analysis, food and flavor, geological science, material science, and semiconductor manufacturing.
Media Contact: Kendra Kimmel - TOFWERK AG Head of Marketing
T: +1 (720) 531 2529 - E: kendra[.]tofwerk.com
About Bruker Corporation
Bruker (bruker.com) is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics.
Investor Contact: Justin Ward - Sr. Director Investor Relations & Corp. Development
T: +1 (978) 663-3660, ext. 1479 - E: Investor.Relations[.]bruker.com.